EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

IL-17 is Associated with Disease Severity and Targetable Inflammatory Processes in Heart Failure

Lukas Baumhove, Bart J van Essen, Martin M Dokter, Sietske N Zijlstra, Frederik E Deiman, Jon D Laman, Chim C Lang, Gwenny M P J Verstappen, Dirk J van Veldhuisen, Peter van der Meer, Nils Bomer, Adriaan A Voors

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.14968 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Lukas Baumhove und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Heart Failure, Interleukin-17, Severity of Illness Index, Biomarkers. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: FP7-242209-BIOSTAT-CHF; EudraCT 2010-020808-29, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Heart failure (HF) is recognized as an inflammatory disease in which cytokines play an important role. In animal HF models, interleukin-17A (IL-17) has been linked to deterioration of cardiac function and fibrosis, whereas knock-out of IL-17 showed beneficial cardiac effects. However, there is limited evidence of IL-17 involvement in patients with HF. This study aims to investigate the clinical characteristics, outcomes, and pathophysiological processes associated with circulating IL-17 concentrations in patients with HF. Methods and results IL-17 was measured by ELISA in 2082 patients diagnosed with HF along with 363 circulating proteins using proximity extension assay technology for differential expression and pathway analysis. Data were validated in an independent cohort of 1737 patients with HF. Patients with elevated IL-17 concentrations had more severe HF, as reflected by more frequent current or previous hospitalizations for HF, higher New York Heart Association functional class (NYHA) and higher levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP). High IL-17 concentrations were independently associated with an increased risk of hospitalization for HF and mortality. In both cohorts, the most strongly up-regulated proteins in patients with high IL-17 were fibroblast growth factor 21 (FGF-21), interleukin-6 (IL-6), C-X-C motif chemokine ligand 13 (CXCL13), tumour necrosis factor receptor superfamily member 6B (TNFRSF6B) and interleukin-1 receptor antagonist (IL-1RA). Pathway over-representation analysis showed increased activity of pathways related to lymphocyte-mediated immunity, leukocyte activation and regulation of the immune response.

Conclusions

In patients with HF, elevated IL-17 concentrations indicate more severe HF and increased activity of inflammatory processes known to be involved in the pathophysiology of HF. IL-17 might hold potential for identifying and targeting inflammation in HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureInterleukin-17Severity of Illness IndexBiomarkersInflammationHumansMaleFemaleAgedMiddle AgedEnzyme-Linked Immunosorbent AssayFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

cytokinesheart failureinflammation

Substanzen

Interleukin-17Biomarkers

Autor:innen und Institutionen

  • Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Pathology & Medical Biology, University Medical Center Groningen, Groningen, The Netherlands.
  • Division of Molecular and Clinical Medicine, School of Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK.
  • Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Förderung

  • FP7-242209-BIOSTAT-CHF; EudraCT 2010-020808-29
  • European Commission

Zitieren

APA

Baumhove, L., van Essen, B. J., Dokter, M. M., Zijlstra, S. N., Deiman, F. E., Laman, J. D., Lang, C. C., Verstappen, G. M. P. J., van Veldhuisen, D. J., van der Meer, P., Bomer, N., & Voors, A. A. (2024). IL-17 is Associated with Disease Severity and Targetable Inflammatory Processes in Heart Failure. ESC Heart Failure. https://doi.org/10.1002/ehf2.14968

Vancouver

Baumhove L, van Essen BJ, Dokter MM, Zijlstra SN, Deiman FE, Laman JD, et al. IL-17 is Associated with Disease Severity and Targetable Inflammatory Processes in Heart Failure. ESC Heart Failure. 2024. doi:10.1002/ehf2.14968

BibTeX
@article{Baumhove2024,
  author = {Baumhove, Lukas and van Essen, Bart J and Dokter, Martin M and Zijlstra, Sietske N and Deiman, Frederik E and Laman, Jon D and Lang, Chim C and Verstappen, Gwenny M P J and van Veldhuisen, Dirk J and van der Meer, Peter and Bomer, Nils and Voors, Adriaan A},
  title = {IL-17 is Associated with Disease Severity and Targetable Inflammatory Processes in Heart Failure},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.14968}
}
Kostenlos starten →